Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monette

Showing results (701-710 of 740) with videos related to

Pageof 74
Sort By:
Aging|February 17, 2016
p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor functionZijun Y Xu-Monette, Shanxiang Zhang, Xin Li, et al.
Leukemia|August 27, 2015
Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL ConsortiumL Deng, Z Y Xu-Monette, S Loghavi, et al.
Oncotarget|March 12, 2015
Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countriesZijun Y Xu-Monette, Meifeng Tu, Kausar J Jabbar, et al.
Nature Microbiology|March 1, 2024
Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host diseaseSarah Lindner, Oriana Miltiadous, Ruben J F Ramos, et al.
Cell|September 18, 2018
An Atypical Parvovirus Drives Chronic Tubulointerstitial Nephropathy and Kidney FibrosisBen Roediger, Quintin Lee, Shweta Tikoo, et al.
Oncotarget|February 24, 2015
Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphomaJiayu Chen, Zijun Y Xu-Monette, Lijuan Deng, et al.
Oncoimmunology|August 7, 2024
DNA mismatch repair defect and intratumor heterogeneous deficiency differently impact immune responses in diffuse large B-cell lymphomaZijun Y Xu-Monette, Cancan Luo, Li Yu, et al.
Blood|March 22, 2013
Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium ProgramYong Li, Michael W Gordon, Zijun Y Xu-Monette, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2015
Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functionsChi Young Ok, Zijun Y Xu-Monette, Ling Li, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 23, 2019
PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium ProgramLing Li, Ruifang Sun, Yi Miao, et al.
Pageof 74

Showing results (701-710 of 740) with videos related to

Sort By:
Pageof 74
Aging|February 17, 2016
p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor functionZijun Y Xu-Monette, Shanxiang Zhang, Xin Li, et al.
Leukemia|August 27, 2015
Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL ConsortiumL Deng, Z Y Xu-Monette, S Loghavi, et al.
Oncotarget|March 12, 2015
Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countriesZijun Y Xu-Monette, Meifeng Tu, Kausar J Jabbar, et al.
Nature Microbiology|March 1, 2024
Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host diseaseSarah Lindner, Oriana Miltiadous, Ruben J F Ramos, et al.
Cell|September 18, 2018
An Atypical Parvovirus Drives Chronic Tubulointerstitial Nephropathy and Kidney FibrosisBen Roediger, Quintin Lee, Shweta Tikoo, et al.
Oncotarget|February 24, 2015
Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphomaJiayu Chen, Zijun Y Xu-Monette, Lijuan Deng, et al.
Oncoimmunology|August 7, 2024
DNA mismatch repair defect and intratumor heterogeneous deficiency differently impact immune responses in diffuse large B-cell lymphomaZijun Y Xu-Monette, Cancan Luo, Li Yu, et al.
Blood|March 22, 2013
Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium ProgramYong Li, Michael W Gordon, Zijun Y Xu-Monette, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2015
Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functionsChi Young Ok, Zijun Y Xu-Monette, Ling Li, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 23, 2019
PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium ProgramLing Li, Ruifang Sun, Yi Miao, et al.
Pageof 74